 |
|
DEPARTMENT OF BIOTECHNOLOGY
(Ministry of Science and Technology) |
|
SMALL BUSINESS
INNOVATION RESEARCH INITIATIVE (SBIRI) |
|
(Call for Proposals
- 8th Batch) |
|
The
Department of Biotechnology (DBT) invites proposals from
Biotech Companies / Entrepreneurs for innovative, early
stage, pre-proof-of-concept research and development &
commercialization of available innovative research leads in
all areas of Biotechnology under the Small Business
Innovation Research Initiative (SBIRI) Scheme. The
scheme provides early stage funding for high risk,
innovative and/or commercializable product proposals.
The model of Public Private Partnership between industry and
public funded institution will be encouraged. |
|
The SBIRI aims to |
|
(i) |
Strengthen existing private
industrial units where product development is based on
in-house innovative R&D. |
|
(ii) |
Create opportunities for
starting new technology-based or knowledge-based business in
biotechnology by science entrepreneurs. |
|
(iii) |
Stimulate technological
innovation and product commercialization. |
|
(iv) |
Use private industries as a
source of innovation and enhance greater public-private
partnerships, and |
|
(v) |
Increase product
development and commercialization in the public-private
sector derived from Government funded R&D projects. |
|
|
ELIGIBILITY: |
|
The proposals can be submitted |
| → |
solely by
an Industry; or |
| → |
jointly by
Industry and National R&D Organizations, Universities and
Institutions; |
| → |
by a group
of industries/users, national research organizations,
universities and institutions etc. |
| |
The
private firm should fulfill the following criteria: |
|
. |
The unit
should be registered in India and must fulfill the criteria of
Small Business Unit as defined in the scheme. |
| . |
The
Company's shares should be held at least to the extent of 51%
by Indian promoters, family and friends and the general
public. |
| . |
The Company
should have well established in-house R&D unit recognized by
Department of Scientific and Industrial Research (DSIR)* or
have patent rights (National or International) on preliminary
work done related to the proposed activity. |
|
[*The
Companies who are in the process of obtaining DSIR recognition
or intend to do so may also apply. Hower final decisions
on their applications will be subject to fulfilment or
eligibility criteria]. |
|
Joint
ventures and limited partnerships would be eligible for SBIRI
support, where the entity created meets the above
requirements. |
|
The
Companies should submit the proposal (5 copies + one soft
copy [ MS Word file and not a PDF file] through E-mail or CD)
strictly in the prescribed format presently available
on the website on or before 30th June, 2008 before 5.30
p.m. to The Executive Director, Biotech Consortium India
Limited (BCIL), 5th Floor Anuvrat Bhawan, 210 Deen Dayal
Upadhyaya Marg, New Delhi-110 002 (E-mail:
bcildelhi@vsnl.com or
bcil@biotech.co.in ),
superscribing "CONFIDENTIAL, SBIRI PROJECT" on the document
holder. BCIL has been approved as the SBIRI Management
Agency by the Department of Biotechnology and will ensure the
confidentiality of the documkents. The proposals with
incomplete information or the proposals that are not in the
prescribed format will not be considered. |
|
Please visit our website at
http://www.dbtindia.gov.in or
http://dbtindia.nic.in
for structure of funding and other details of the scheme.
This advertisement is also available on the website. All
future advertisements will also be displayed on the website. |
For any further information
and clarifications pertaining to the Scheme, please contact:
Dr.(Mrs.) Suchita Ninawe,
Scientist 'E', Department of Biotechnology, Ministry of
Science & Technology, CGO Complex, Block 2, 6-8th floor, Lodhi
Road, New Delhi-110 003. |
|
|
Next
advertisement is expected to be issued during September-October,
2008 |
|